Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CNDO 109

Drug Profile

CNDO 109

Alternative Names: Allogeneic tumour activated natural killer lymphocytes; CNDO-102; CNDO-109; CNDO-109-AANK Cells; CNDO-109-activated allogeneic NK cell therapy; CNDO-109-NK

Latest Information Update: 22 Feb 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University College London
  • Developer Fortress Biotech
  • Class Antineoplastics; Biological intercellular signalling peptides and proteins; Immunotherapies; Natural killer cell therapies
  • Mechanism of Action Natural killer cell stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Acute myeloid leukaemia
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Acute myeloid leukaemia; Multiple myeloma; Solid tumours

Most Recent Events

  • 22 Feb 2023 Discontinued - Phase-I/II for Acute myeloid leukaemia (Prevention of relapse) in USA (IV)
  • 22 Feb 2023 Discontinued - Preclinical for Multiple myeloma in USA (IV)
  • 04 Apr 2019 Coronado Biosciences completes a phase I/II trial for Acute myeloid leukaemia in the USA

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top